Brittany Ice Bucket Challenge
We are donating to Midwest Stem-cell Research Center to combat ALS. They are pro-life and so are we.
By: Joey Morse
Original post:
Brittany Ice Bucket Challenge - Video
Posted: August 24, 2014 at 10:48 am
Brittany Ice Bucket Challenge
We are donating to Midwest Stem-cell Research Center to combat ALS. They are pro-life and so are we.
By: Joey Morse
Original post:
Brittany Ice Bucket Challenge - Video
Posted: August 24, 2014 at 7:56 am
October 14, 2013
Sarah Keblin Vermont Cancer Center University of Vermont (802) 656-3099
Michael Carrese Fletcher Allen Health Care (802) 847-2886
The Vermont Cancer Centers Stem Cell Transplant Program at Fletcher Allen Health Care recently received accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) located at the University of Nebraska Medical Center.
FACT accreditation is validation for the programs outstanding capabilities and quality in treating patients with leukemia, lymphoma and other forms of cancer with stem cell therapy. The accreditation specifically recognizes quality in autologous adult stem cell transplantation - in which healthy stem cells are collected from an individual and re-introduced to that person as well as cell collection, and cell processing.
Stem cells are typically found in bone marrow and the bloodstream and help form the critically important red and white blood cells and platelets often destroyed by high-dose chemotherapy and/or radiation therapy treatments for cancer. Stem cell transplants following these therapies support the bone marrows ability to produce the blood cells the patient needs.
This accreditation validates an already strong program with a history of excellence and recognizes our organizations daily commitment to high-quality patient care within the adult stem cell transplant program, said Julian Sprague, M.D., assistant professor of Medicine in the division of Hematology and Oncology at the University of Vermont and Fletcher Allen, and director of the Stem Cell Transplant Program at the Vermont Cancer Center.
Accreditation by FACT brings with it notable advantages for the Vermont Cancer Center, its partners, and the patients they serve. Adherence to FACT standards is increasingly necessary for both health insurance and government funding eligibility and will provide opportunities for the academic medical center to invest further in research, and to expand its services, in cellular therapies. In just the last week, in response to this accreditation, one of Vermonts major insurance plans has approved the program for reimbursement, increasing coverage and access for patients here in Vermont and the region to receive this life-saving treatment.
Patients seek FACT accredited programs when looking for care, and we know that enabling patients to receive treatment close to home is highly advantageous in helping them to maintain a normal life and also in increasing positive outcomes for them and their families, said Sprague. Im incredibly proud of the team here at Fletcher Allen and the Vermont Cancer Center and what they have done and will continue to do for patients.
Go here to read the rest:
The Vermont Cancer Center's Stem Cell Transplant Program ...
Posted: August 24, 2014 at 7:52 am
The state of maine in the United States has no specific laws regarding stem cell research, though the state has a long history in progressive biomedi-cal research dating back to the founding of Jackson Laboratory on Mt. Desert Island in 1929. The state has made a commitment to monetary investment in research and development for their modest biomedicine industry to support innovation while creating jobs and improving the economy.
In March 2007 a bill (LD 1402 An Act to Authorize a General Fund Bond Issue to Enhance Funding for Stem Cell Research in Maine) was introduced into the Maine legislature. The bill would have directed bond revenue to fund stem cell research and establish an umbilical cord bank in the state. Along with the bill, the sponsor offered an amendment to limit the funding to adult stem cells to avoid the embryonic stem cell controversy. However, the bill did not progress and appears to be dead due to legislative rules.
With no federal funding available for stem cell research, Maine researchers must rely on grant money and state support. In 2006 the governor made funding of stem cell research a priority and set a goal of achieving $1 billion annual expenditure on biomedical research in Maine by the year 2010. Investment by the State of Maine on building infrastructure (labs and equipment) is expected to result in a return on investment through grant funding from outside sources, including a recent National Institutes of Health grant and opportunities for increased biotech business development in commercially viable products and therapies.
Jackson Laboratory in Bar Harbor was started in 1929 by Clarence Cook Little as a cancer research facility. The mission of Jackson Laboratory is to perform primary genetic research and provide resources and education to support other researchers in treating human disease. To meet this goal, the laboratory breeds mice, inducing over 800 varieties of targeted genetic traits and diseases. These mice as well as frozen embryos and DNA samples are available for shipment to investigators worldwide.
In addition to the breeding program, researchers at Jackson Laboratory are studying cancers, immunology, neurobiology, metabolic diseases, developmental and reproductive biology and computational biology (genes). In 1956 a research team at Jackson Lab transplanted blood forming cells from the living into anemic mice. The majority of the anemic mice were cured within 60 days, providing the first evidence of stem cell transplant ability to cure disease.
Current stem cell research in animal models includes the use of adult stem cells as possible treatment for genetic disorders like lysosomal storage disease, minimizing the effect of graft-versus-host disease after stem cell transplant and the direct implantation of neuronal stem cells into the brain to solve the problem of minimal stem cell entry into the central nervous system.
The Maine Medical Center Research Institute (MMCRI) in Scarborough opened in 1996. With both laboratory and clinical research spaces, the institute maintains academic ties with the University of Maine at Orono, University of Vermont Medical School, Dartmouth Medical School, the Jackson Laboratory, and the University of New England College of Osteopathic Medicine. The center grew from the previous success in research with funding from the National Institutes of Health dating back to the 1950s. At MMCRI, a research team identified signaling pathways and the genes controlling stem cell renewal and differentiation as well as discovering the possibility of using adult stem cells in developing a wide range of tissue cells. The institute focuses on research, education, and patient care.
The University of Maine at Orono opened in 1868 and over time developed a reputation as a nationally recognized research school. In collaboration with the Maine Medical Center Research Institute and the Jackson Laboratory, the university now offers a Ph.D. program in functional genom-ics, which includes laboratory rotations at each partners institution and encourages having more than one mentor to enhance understanding of the biological mechanisms as well as the technology. Current stem cell research at the university is focused on the analysis of cell surface proteins for signaling and response as well as the dynamic processes involved.
The Mount Desert Island Biological Laboratory located in Salisbury Cove was founded in 1898 as the Tufts Summer School of Biology. The mission of the laboratory is the study of marine life for advancing knowledge of developmental and life mechanisms with correlations to human health, especially in the areas of cardiovascular, pulmonary, and renal disease. The laboratory has the special distinction of being one of only four NIEHS Marine and Freshwater Biomedical Science Centers.
See more here:
Posted: August 24, 2014 at 7:51 am
The Indiana university system consists of eight regional campuses offering undergraduate, graduate, and professional programs in a variety of academic disciplines including medicine, biology, engineering, math, and physical sciences. Although the flagship undergraduate university campus is located in Bloomington, the medical school and medical research is located in Indianapolis. In agreement with Indianas law regarding stem cell research, Indiana Universitys stem cell research focuses on adult-source stem cells.
In 2007 the Indiana legislature approved the establishment of, and appropriated $50,000 for, an Adult Stem Cell Research Center at Indiana University. The legislature gave the Indiana University School of Medicine approval to administer the center, including appointing a director and accepting income from donations, gifts, and so on, to be used to support the centers activities. The center will be tasked with providing an assessment of the status and future of adult stem cell research and with devising a strategy for Indiana University to attract and retain adult stem cell research scientists.
The Indiana University School of Medicine was established in 1903 and has established itself as a research center for both basic and clinical research. A highlight in its adult stem cell research includes an early clinical trial using stem cell injections for treating peripheral artery disease (clogging atherosclerosis and hardening of arteries) to demonstrate the safety of using stem cells for blood vessel growth and wound healing, as the stem cells/progenitor cells targeted the lining of the blood vessel. With additional research, the team hopes to find a therapy to restore adequate stem cells in patients with heart disease or at risk for heart disease so that the body will be able to repair or replace damaged blood vessels and prevent the progression of heart disease.
Using a patients own stem cells from bone marrow could reduce the complications associated with such a transplant. Research is currently focused on the regeneration of limbs/digits, cardiovascular system, musculoskeletal system, neural/endocrine system, biomaterials and chemical biology, bioinfor-matics and systems biology, and cancer.
The Melvin and Bren Simon Cancer Center, founded in 1992 and renamed in 2006, part of the School of Medicine. The center provides patient care, education, and research opportunities. Research is focused on improving cancer care with gene therapy trials for testicular cancer, brain tumors, genetic diseases, and other disorders.
The Center for Regenerative Biology and Medicine was established in 2001 through a grant from the state of Indianas 21st Century Research and Technology Fund. It is a multidisciplinary collaboration between the universitys School of Science and the School of Medicine. The centers research is coordinated through multiple academic disciplines, including the basic science behind the development of cells/tissue/organs and the regeneration capabilities of plants and animals for translation into human clinical therapies to repair damaged or diseased tissue.
The center has nine organized research programs: regeneration of appendages, blood, heart, musculoskeletal, neural, endocrine, plant, and cancer, as well as the basic science of biomaterials and chemical biology and of bioinformatics and systems biology, and a focus on bioethical issues associated with the field of regenerative science and medicine.
In addition to research, the center offers graduate-level education leading to masters and doctoral degrees in regenerative biology and medicine with a cross-discipline approach.
The Emerging Technology Center helps researchers translate basic science innovations into clinical/commercial applications by assisting with new business development, including developing business plans and arranging financing.
One example of the centers success is EndGeni-tor Technologies, founded by two physicians at the Indiana University School of Medicine, who discovered endothelial stem cells/progenitor cells by comparing adult blood cells with infant umbilical cords to create cell therapy products for treating extremities circulation problems/heart disease and problems with blood vessels and circulation, as well as for treating chronic problems associated with aging. The physicians are owners in the company and continued to teach at the university after hiring a chief executive officer and support staff.
See the original post:
Posted: August 23, 2014 at 10:44 am
Stem Cells Simply Explained
Stem Cells Explanation Video.
By: Addam Smith
Read this article:
Stem Cells Simply Explained - Video
Posted: August 23, 2014 at 10:44 am
Djuana Testimonial Twilight Face Lift with Stem Cells
This video is about djuana testimonial twilight.
By: Tammy Tucker
Visit link:
Djuana Testimonial Twilight Face Lift with Stem Cells - Video
Posted: August 23, 2014 at 10:44 am
46 1 Ning -spinal cord injury of C4-C5 (male, 26-year-old) - Before stem cell treatment
Ning, a 26-year-old guy, happened to fall down from a high level in September, 2006, which led to his spinal cord injury of C4-C5 and remained quadriplegia, incontinence of urination and bowl...
By: Stem Cells
More:
46 1 Ning -spinal cord injury of C4-C5 (male, 26-year-old) - Before stem cell treatment - Video
Posted: August 23, 2014 at 10:44 am
52 1 Mr. Wu -Lumbar Vertebra Injury (male, 22-year-old) - Before stem cell treatment
Mr. Wu, 22 years old, happened to fall down on June 9th, 2011, which led to the 1st Lumbar vertebra injury. He received physical rehabilitation therapy after the injury, but the achieved improvemen...
By: Stem Cells
Here is the original post:
52 1 Mr. Wu -Lumbar Vertebra Injury (male, 22-year-old) - Before stem cell treatment - Video
Posted: August 23, 2014 at 10:44 am
31 2 Mrs. Han -C4-C6 Spinal Cord Injury (Female, 39-year-old) - After stem cell treatment
Mrs. Han, 39 years old, suffered from movement dysfunction, sensation disorder over 1 year after C4-C6 spinal cord injury. She received 1st round stem cell treatment in our hospital in November,...
By: Stem Cells
Read this article:
31 2 Mrs. Han -C4-C6 Spinal Cord Injury (Female, 39-year-old) - After stem cell treatment - Video
Posted: August 23, 2014 at 10:44 am
Critical transport: Bond LSC team finds boron vital for plant stem cells, corn reproduction
Tiny amounts of boron play a key part in the development of ears and tassels on every cornstalk. The journal Plant Cell published research from the lab of Paula McSteen in its July 2014 edition,...
By: mubondlsc
View original post here:
Critical transport: Bond LSC team finds boron vital for plant stem cells, corn reproduction - Video